792 Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer
| Autor: | Ke Xu, Zhengyi Wang, Jaeho Jung, Xuejun Liu, Jie Xia, Ao Li, Andrew Zhu, Jane Meng, Chenyu Pan, Zhenhu Li |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2023-SITC2023.0792 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|